Orbimed Advisors LLC Vir Biotechnology, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,218,617 shares of VIR stock, worth $31.2 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
3,218,617
Previous 3,573,000
9.92%
Holding current value
$31.2 Million
Previous $26.8 Million
11.72%
% of portfolio
0.64%
Previous 0.63%
Shares
5 transactions
Others Institutions Holding VIR
# of Institutions
230Shares Held
90.1MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$162 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$127 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$49.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$21.3 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.29B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...